NCT01463072View on ClinicalTrials.gov

Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 19, 2012

Primary Completion Date

May 17, 2017

Study Completion Date

May 18, 2026

Conditions
Locally Advanced Breast CarcinomaMetastatic Breast CarcinomaRecurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

Nab-paclitaxel

Given IV

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (4)

43210

Ohio State University Comprehensive Cancer Center, Columbus

91010

City of Hope medical, Duarte

91030

City of Hope South Pasadena, South Pasadena

93534

City of Hope Antelope Valley, Lancaster

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER